Crescent Capital BDC AI Stock Analysis
Want to see CCAP full AI Analyst Report?
Crescent Capital BDC (CCAP) AI Stock Analysis
Crescent Capital BDC
(NASDAQ:CCAP)
Overall score reflects mid-range financial performance driven by solid revenue growth but sharply weaker profitability and softer free-cash-flow momentum. The earnings call was a relative positive (NII covering the dividend, no new nonaccruals, and planned JV/buybacks aimed at deleveraging), while technicals are mixed (below longer-term moving averages). Valuation is helped by the very high dividend yield, but the negative P/E tempers the valuation signal.
Crescent Capital BDC (CCAP) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $377.67M
- Dividend Yield
- 15.41%
- Average Volume (3M)
- 252.48K
- Price to Earnings (P/E)
- -1025.0
- Beta (1Y)
- 0.59
- Revenue Growth
- -21.64%
- EPS Growth
- -100.43%
- Country
- US
- Employees
- 250
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
Crescent Capital BDC Business Overview & Revenue Model
Company Description
Crescent Capital BDC, Inc. functions as a Business Development Company (BDC), managing a fund dedicated to private equity, leveraged buyouts, and providing loan capital. The firm's strategy centers on making direct investments, with a specific focus...
How the Company Makes Money
CCAP makes money primarily from investment income generated by its portfolio of loans and other investments. The core revenue stream is interest income earned on debt investments (most commonly senior secured loans) made to middle-market borrowers; t...
Crescent Capital BDC Earnings Call Summary
The call was broadly positive, supported by net investment income above the regular dividend, stable overall portfolio performance, no new nonaccruals, strong platform commitments, substantial liquidity, and announced share repurchase and joint venture initiatives. However, the company continues to face subdued LBO activity, delayed realizations, leverage above its long-term target, a higher watch-list percentage, limited new deployment and ongoing credit-management challenges. The positive operating results and shareholder-support initiatives significantly outweighed the stated challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
CCAP expects the unconsolidated joint venture to be completed during the fourth quarter of 2026, seeded with approximately $150 million of performing first lien assets, with CCAP committing $30 million of equity and the joint venture equity partner contributing $30 million, alongside an ABL facility; the company is targeting a low to mid-teens ROE, expects the joint venture to be accretive to gross yield, and expects its total size to be around $150 million to $200 million, or roughly 2% of the portfolio, going forward. CCAP expects to use JV proceeds to reduce leverage to its target range and fund its $50 million share repurchase program, while Sun Life will purchase up to an additional $25 million of shares at certain thresholds below net asset value per share; pending portfolio realizations and the joint venture are expected to bring net leverage to within the target range by year-end. The company is not contemplating any further JVs in the near term, expects the JV to be a permanent part of the CCAP portfolio in the near term and to replenish assets as the initial seed portfolio rotates, and expects a pickup in activity going into 2027.
Crescent Capital BDC Financial Statement Overview
Summary
Mid-range fundamentals: TTM revenue growth is solid (+12.5%), but profitability and returns weakened sharply (TTM net margin ~2.7% vs much higher prior years; slightly negative ROE TTM). Cash generation remains positive (~$33.1M OCF/FCF), though FCF is materially down (~-43% TTM). Balance sheet signals are mixed, with historically meaningful leverage and improved reported TTM debt levels, but current profitability pressure.
Income Statement
54NeutralBalance Sheet
57NeutralCash Flow
60Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.81M | 156.19M | 142.44M | 147.33M | 52.10M | 101.10M |
| Gross Profit | 68.68M | 121.85M | 83.50M | 92.46M | 23.17M | 84.93M |
| EBITDA | 35.09M | 97.07M | 74.74M | 84.11M | 16.50M | 87.28M |
| Net Income | 3.42M | 34.51M | 73.65M | 83.84M | 15.54M | 83.63M |
Balance Sheet | ||||||
| Total Assets | 1.60B | 1.62B | 1.66B | 1.63B | 1.30B | 1.32B |
| Cash, Cash Equivalents and Short-Term Investments | 36.20M | 5.04M | 10.13M | 7.78M | 6.40M | 10.07M |
| Total Debt | 0 | 873.76M | 875.84M | 844.78M | 654.46M | 631.04M |
| Total Liabilities | 948.51M | 916.10M | 915.64M | 884.78M | 690.34M | 665.52M |
| Stockholders Equity | 652.93M | 706.04M | 740.64M | 742.59M | 612.54M | 652.28M |
Cash Flow | ||||||
| Free Cash Flow | 33.11M | 74.72M | 82.75M | 61.81M | 58.38M | 28.45M |
| Operating Cash Flow | 33.11M | 74.72M | 82.75M | 61.81M | 58.38M | 28.45M |
| Investing Cash Flow | -27.48M | 0 | -23.85M | 30.48M | -30.43M | -186.11M |
| Financing Cash Flow | -24.64M | -82.54M | -43.47M | -84.99M | -34.41M | 166.32M |
Crescent Capital BDC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCAP, the sentiment is Positive. The current price of 10.25 is above the 20-day moving average (MA) of 9.18, above the 50-day MA of 9.31, and below the 200-day MA of 10.82, indicating a neutral trend. The MACD of 0.19 indicates Negative momentum. The RSI at 67.46 is Neutral, neither overbought nor oversold. The STOCH value of 76.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CCAP.
Crescent Capital BDC Risk Analysis
Crescent Capital BDC disclosed 1 risk factors in its most recent earnings report. Crescent Capital BDC reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksCrescent Capital BDC Peers Comparison
Overall Rating
BBDC70Outperform
CION65Neutral
SCM63Neutral- CCAP62Neutral
TCPC60.5Neutral
SAR42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| BBDC | 70Outperform | $918.28M | 10.32 | 7.89% | 8.89% | 1.24% | -12.68% |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| CION | 65Neutral | $312.44M | -13.00 | -3.95% | 21.35% | -13.70% | -238.64% |
| SCM | 63Neutral | $193.87M | 11.69 | 0.00% | 18.96% | -11.79% | -47.23% |
| CCAP | 62Neutral | $382.46M | -1025.00 | -0.02% | 15.41% | -21.64% | -100.43% |
| TCPC | 61Neutral | $346.52M | -1.76 | -36.53% | 18.31% | -374.71% | -2111.43% |
| SAR | 42Neutral | $196.21M | -50.72 | -1.08% | 25.63% | -10.96% | -110.82% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CCAP | Crescent Capital Bdc, Inc. | 10.25 | -1.61 | -13.57% | |
| SAR | Saratoga Investment | 12.68 | -6.32 | -33.26% | |
| BBDC | Barings Bdc | 8.77 | 0.83 | 10.47% | |
| SCM | Stellus Capital Investment | 6.75 | -3.72 | -35.56% | |
| TCPC | BlackRock TCP Capital Corp. | 4.15 | -0.69 | -14.22% | |
| CION | Cion Investment Corp. | 6.37 | -2.08 | -24.62% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 10, 2026